Lauren Barnes

Born 1974. Member of the board of directors since 2020. Chairman of Commercialization Committee

Professional background: Lauren Barnes is Senior Vice President of Strategic Market Development and Access, previously Senior Vice President of Market Access for Blueprint Medicines (listed on Nasdaq), a commercial stage Boston based precision medicine company. Lauren Barnes has extensive expertise and experience in pricing, market access, pre-commercialization and managed markets in particular for the US market. She has been involved in launch planning of more than 50 drugs, devices and diagnostics during her career. Prior to her current role Lauren was Vice President at Vertex Pharmaceuticals, Senior Vice President Avalere Health and has also held various roles at Amgen and the agency that runs the United States Medicare Program, the Centers for Medicare and Medicaid Services. She was previously Chair of the Cancer Support Community.

Education: MHS in Public Health from the Johns Hopkins School of Public Health and BA in Public Health from the Johns Hopkins University.

Other ongoing assignments: MHS in Public Health from the Johns Hopkins School of Public Health and BA in Public Health from the Johns Hopkins University.

Holdings in Ascelia: View holdings

Independence: Independent in relation to the Company and its management and in relation to major shareholders.